ライフサイエンスコーパス: mean blood pressure

1 nosis and treatment focus only on underlying mean blood pressure.

2 risk of stroke and expected effects based on mean blood pressure.

3 SD) and as transformations uncorrelated with mean blood pressure.

4 -stimulus period and significantly increased mean blood pressure.

5 input, thus contributing to the increase in mean blood pressure.

6 The primary outcome was the change in 24-h mean blood pressure.

7 height correlated with all variables except mean blood pressure.

8 fort of the left ventricle, even at the same mean blood pressures.

9 onset of stretch) by a transient increase in mean blood pressure (101.9 +/- 0.3%, P < 0.05) from the

10 usion alone had a small effect of increasing mean blood pressure (12 +/- 3 mm Hg), which in itself di

11 D) age of the patients was 64+/-8 years, the mean blood pressure 133+/-17/78+/-10 mm Hg, and the mean

12 56 patients, mean blood pressure 161/98 mm Hg, entered the rotation,

13 All patients were hypertensive (mean blood pressure: 194/103 mmHg; mean medications: 2.4

14 group achieved a greater decrease in 24-hour mean blood pressure (3.1 mm Hg [95% CI, 0.6 to 5.6]; P =

15 plus laparotomy) or T-H (midline laparotomy, mean blood pressure 35 +/- 5 mmHg for 90 min, followed b

16 (midline laparotomy) and hemorrhagic shock (mean blood pressure 35-40 mm Hg for 90 minutes) followed

17 ximately 300 g) underwent trauma-hemorrhage (mean blood pressure, 40 mm Hg for 90 min, then resuscita

18 We analysed the associations between mean blood pressure achieved on treatment; prerandomisat

19 primary end point was the change in 24-hour mean blood pressure after 12 weeks.

20 during BAO not only prevented the increased mean blood pressure after forced exercise, but also sign

21 Mean blood pressures after dose adjustment were 131.6/73

22 of stroke more than expected on the basis of mean blood pressure alone and that beta blockers are les

23 The magnitude of spontaneous changes in mean blood pressure and CBF velocity were quantified by

24 was no difference in the 24-hour rhythms of mean blood pressure and heart rate between the two group

25 ated coffee, and total caffeine intakes with mean blood pressure and incident hypertension in postmen

26 ciation of OAG with systolic, diastolic, and mean blood pressures and perfusion pressures.

27 deviation [SD] and parameters independent of mean blood pressure) and maximum blood pressure in patie

28 in, hemoglobin A1c levels, serum creatinine, mean blood pressure, and mean number of antihypertensive

29 Rats underwent trauma-hemorrhage (mean blood pressure approximately 40 mm Hg for 90 mins)

30 The mean blood pressure before ablation was 149/90 mm Hg wit

31 L-DOPS significantly raised mean blood pressure both supine (from 101+/-4 to 141+/-5

32 in response to proportionate (%) changes in mean blood pressure (BP) induced by stepwise sodium nitr

33 eprocedure and postprocedure heart rates and mean blood pressures compared with patients who were not

34 Mean blood pressure declined from 146/86 mmHg to 134/72

35 The mean blood pressure decreased to 134/77 mm Hg 1 month af

36 Heart rate and mean blood pressure during echo and catheterization were

37 Overall mean blood pressure fell from 173/99 mm Hg (SD 14/8) to

38 Mean blood pressure from both techniques may be interpre

39 After 12 months, the mean blood pressure had decreased to 128.2/73.8 mm Hg in

40 planted 1 week before starting the diet, and mean blood pressure, heart rate, and motor activity were

41 dex, mean arterial blood pressure, change in mean blood pressure, heart rate, change in heart rate, t

42 gnificant changes in systolic, diastolic, or mean blood pressure, heart rate, or IOP during all four

43 ssociated with age, sex, height, heart rate, mean blood pressure, hemoglobin level, country, and hemo

44 Mean blood pressure increased by 10 +/- 1 mm Hg, and hea

45 Mean blood pressure levels and rates of awareness, treat

46 257) and compared differences in accumulated mean blood pressure levels at sequential times in the tr

47 blood pressure-lowering treatment group had mean blood pressure levels of 133/76 mm Hg, compared wit

48 The mean blood pressure levels of men and women in the gener

49 Systemic mean blood pressure (MAP) was monitored through a cathet

50 s produced earlier and greater reductions in mean blood pressure (MBP) and increased, rather than dec

51 Comparative effects on heart rate (HR) and mean blood pressure (MBP) were also studied.

52 Heart rate and mean blood pressure (mBP) were monitored throughout the

53 Kir2.1(+/-) mice also show increased mean blood pressure measured by carotid artery cannulati

54 The mean blood pressure, minimum lumen diameter (MLD), numbe

55 e treatment group had a significantly higher mean blood pressure (mm Hg) (110+/-6 group 3; 86+/-7 gro

56 on was discontinued in cases of decreases in mean blood pressure of > or =20% or intolerable itching.

57 cebo (moderate blood pressure control) had a mean blood pressure of 137+/-0.7/81+/-0.3 mm Hg over the

58 Unheparinized male rats were bled to a mean blood pressure of 45 +/- 3 mmHg.

59 Animals were bled to a mean blood pressure of 45 mmHg (1 mmHg = 133 Pa) and res

60 The mean blood pressure of all animals was above 65 mm Hg, i

61 The mean blood pressure of the participants at baseline was

62 There was a diurnal-to-nocturnal decrease in mean blood pressure only in the glaucoma group.

63 e in heart rate but no significant change in mean blood pressure or vascular resistance.

64 potential covariates that were analyzed were mean blood pressure, patient acuity using the Simplified

65 Rectal and cranial temperatures, mean blood pressure, plasma glucose and blood gases were

66 The change in mean blood pressure produced by HM administration as a f

67 ours of CPAP use and the decrease in 24-hour mean blood pressure (r = 0.29, P = .006), SBP (r = 0.25;

68 se in rcSO2 was negatively correlated to the mean blood pressure (r = 0.60, p < 0.0001).

69 creased Akt activity in the brain, decreased mean blood pressure, reduced cerebral infarct volume, an

70 h AV than with ventricular pacing (change in mean blood pressure +/- SE: 10 +/- 3 vs. 2 +/- 2 mm Hg a

71 chniques in the ICU and whether systolic vs. mean blood pressures should be targeted in therapeutic p

72 Each subject's mean blood pressure, the slope of the regression of his

73 Mean blood pressure, total cholesterol, LDL-cholesterol,

74 our patients had elevated blood pressure but mean blood pressure values were not statistically differ

75 fusion of phenylephrine and normalization of mean blood pressure variability by oscillatory lower bod

76 very low frequency range (0.02 to 0.07 Hz), mean blood pressure variability decreased significantly

77 Baseline 24-hour mean blood pressure was 103.4 mm Hg; systolic blood pres

78 During the trial phase, the mean blood pressure was 130/78 mm Hg in the intensive-co

79 The mean blood pressure was 138 +/- 19/79 +/- 11 mm Hg, rend

80 At baseline, the mean blood pressure was 151/88 and 151/83 mm Hg for the

81 ate was 85 (SD 19) mL/min per 1.73 m(2), and mean blood pressure was 175/98 (SD 16/14) mm Hg.

82 Their mean blood pressure was greater despite more intensive a

83 Mean blood pressure was higher in SHR versus WKY (P<0.01

84 main contributor to systolic, diastolic and mean blood pressure was level of PMN elastase.

85 A significant treatment effect on mean blood pressure was observed (-9.0 mm Hg; 95% confid

86 The mean blood pressure was significantly reduced after dial

87 Mean blood pressure was similar in rats with 2K-1C hyper

88 Heart rate and mean blood pressure were monitored in all animals.

89 Heart rate and mean blood pressure were monitored.

90 During the cohort phase, corresponding mean blood pressures were 131/78 mm Hg and 134/78 mm Hg.

91 ing in both systole and diastole, as well as mean blood pressure, were more compromised in rats bred

92 blood-pressure-lowering drugs should reduce mean blood pressure without increasing variability; idea